EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers

Muhammad Masroor Hussain iD, Sana Qammar, Ju-Mei Wang, Ao-Qiang Zhai, Fu-Yu Li iD, Hai-Jie Hu

Journal of Gastroenterology and Hepatology · 2026-03 · 41 (3) · 895-913

DOI: 10.1111/jgh.70281 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 15.02.2026. Verfasst von Muhammad Masroor Hussain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Artificial Intelligence, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: 1.3.5 Project for Disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University, 1.3.5 Project for Artificial Intelligence, West China Hospital, Sichuan University, National Natural Science Foundation of China for Young Scientists Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive cancers, typically diagnosed at an advanced stage due to its subtle and often absent early symptoms. Despite representing only 3% of new cancer cases, it is projected to become the second leading cause of cancer‐related deaths by 2030. Currently, early diagnosis remains a significant challenge, and survival rates remain poor due to the lack of effective screening tools.

Methods

We conducted a comprehensive literature review to explore the most recent advances in PDAC detection, focusing on novel biomarkers, liquid biopsies, artificial intelligence (AI)–enhanced imaging, and non‐invasive surveillance strategies. We examined the role of circulating tumor DNA (ctDNA), microRNAs, and volatile organic compounds (VOCs) as diagnostic tools, alongside the integration of advanced imaging modalities like MRI, EUS, and MRCP in high‐risk individuals, including those with hereditary cancer syndromes.

Results

Emerging technologies, such as AI‐driven imaging and liquid biopsy, have shown promising improvements in detecting PDAC at earlier, potentially resectable stages. Surveillance strategies for high‐risk populations, including BRCA1/2 mutation carriers and individuals with Lynch syndrome, have demonstrated increased detection of Stage I PDAC, offering a significant opportunity for curative intervention. AI and machine learning techniques are also enhancing the sensitivity and specificity of imaging, providing a new frontier in early‐stage diagnosis.

Conclusion

The integration of molecular diagnostics, advanced imaging technologies, and AI may enable a paradigm shift in PDAC detection, transitioning from late to early‐stage diagnosis and potentially improving survival rates. However, further clinical validation and standardization of these technologies are essential to ensure their widespread clinical adoption. The future of PDAC detection lies in a multimodal, personalized approach, optimizing diagnostic accuracy and early intervention for high‐risk individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsArtificial IntelligenceEarly Detection of CancerBiomarkers, TumorCarcinoma, Pancreatic DuctalGenomicsHumansMicroRNAsLiquid BiopsyCirculating Tumor DNATime Factors

Stichwörter der Autor:innen

artificial intelligencectDNAearly detectionhigh‐risk surveillanceliquid biopsymiRNAnoninvasive biomarkerspancreatic ductal adenocarcinomaradiomics

Substanzen

Biomarkers, TumorMicroRNAsCirculating Tumor DNA

Autor:innen und Institutionen

  • Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
  • Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, China.
  • Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, Pakistan.

ORCID-Profile: Muhammad Masroor Hussain, Fu-Yu Li

Förderung

  • 1.3.5 Project for Disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University
  • 1.3.5 Project for Artificial Intelligence, West China Hospital, Sichuan University
  • National Natural Science Foundation of China for Young Scientists Fund
  • Sichuan Natural Science Foundation
  • Sichuan Science and Technology Program
  • Sichuan University-Sui Ning School-Local Cooperation Project
  • Postdoctoral Research Fund of West China Hospital, Sichuan University
  • (Qilu) Clinical Research of Sichuan Anticancer Association

Zitieren

APA

Hussain, M. M., Qammar, S., Wang, J. M., Zhai, A. Q., Li, F. Y., & Hu, H. J. (2026). Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. Journal of Gastroenterology and Hepatology, 41(3), 895-913. https://doi.org/10.1111/jgh.70281

Vancouver

Hussain MM, Qammar S, Wang JM, Zhai AQ, Li FY, Hu HJ. Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. Journal of Gastroenterology and Hepatology. 2026;41(3):895-913. doi:10.1111/jgh.70281

BibTeX
@article{Hussain2026,
  author = {Hussain, Muhammad Masroor and Qammar, Sana and Wang, Ju-Mei and Zhai, Ao-Qiang and Li, Fu-Yu and Hu, Hai-Jie},
  title = {Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {895--913},
  doi = {10.1111/jgh.70281}
}
Kostenlos starten →